Misonix Announces the Second Largest U.S. Commercial Payer Has Provided Coverage for TheraSkin® to Treat All Lower Extremity Dermal Wounds Adding 32 Million New Covered Lives
18 déc. 2020 10h14 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Dec. 18, 2020 (GLOBE NEWSWIRE) -- 2020) – Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that...
MISONIX REPORTS PRELIMINARY FISCAL 2020 THIRD QUARTER REVENUE OF APPROXIMATELY $17.9 MILLION
02 avr. 2020 10h00 HE
|
MISONIX, Inc.
With Focus on Maintaining Our Objective of Shareholder Value Creation, Company to Prioritize Cash Preservation Through Expense Reduction, Workforce Efficiency and Operational Synergies ...
Misonix Reports Record Quarterly Revenue of $19.7 Million for Fiscal 2020 Second Quarter
05 févr. 2020 16h05 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Announces Public Offering of Common Stock
22 janv. 2020 16h01 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Announces Results of New Large Real-World Studies That Further Prove the Clinical Effectiveness of TheraSkin
05 déc. 2019 09h30 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix to Report Fiscal 2020 First Quarter Financial Results and Host Conference Call and Webcast on November 7
28 oct. 2019 08h30 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...